<DOC>
	<DOCNO>NCT02272556</DOCNO>
	<brief_summary>Patients undergo magnetic resonance spectroscopy ( MRS ) scan noninvasively measure intracerebral plasma metabolite level baseline follow 2 4 hour hyperglycemia . Subjects also undergo lumbar puncture separate occasion ass cerebrospinal fluid level metabolite .</brief_summary>
	<brief_title>Investigating Role Polyol Pathway Central Nervous System</brief_title>
	<detailed_description />
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>Type 2 DM HbA1C treat metformin , sulfonylurea , insulin , combination OR agematched , nondiabetic obese ( BMI &gt; 30 kg/m^2 ) OR agematched lean , healthy control subject ( BMI &lt; 25 kg/m^2 ) Age 1855 BMI 1845 kg/m^2 Creatinine &gt; 1.5 mg/dL Hgb &lt; 10 mg/dL ALT &gt; 2.5 x ULN Untreated thyroid disease Uncontrolled Hypertension Known Neurological Disorders Untreated Psychiatric Disorders Malignancy Bleeding Disorders Smoking Current recent steroid use last 3 month Illicit drug use Pregnancy , actively seek pregnancy , breastfeed Inability enter MRI/MRS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>